Related Experiment Videos
Lichen sclerosus et atrophicus and scleroderma
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|February 12, 1972
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Search for a Sub-eV Sterile Neutrino Using Daya Bay's Full Dataset.
Physical review letters·2024
Improved Measurement of the Evolution of the Reactor Antineutrino Flux and Spectrum at Daya Bay.
Physical review letters·2023
Precision Measurement of Reactor Antineutrino Oscillation at Kilometer-Scale Baselines by Daya Bay.
Physical review letters·2023
First Measurement of High-Energy Reactor Antineutrinos at Daya Bay.
Physical review letters·2022
Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Early Online.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
LDL-cholesterol targets and lipid-lowering therapies - a plea to medical schemes and the Council for Medical Schemes.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
A rare case of paraneoplastic dermatomyositis secondary to smouldering multiple myeloma referred for proteinuria.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Analysis of adverse events following COVID-19 vaccination and infection: A retrospective, comparative cohort study using a claims database from Discovery Health, a managed care organisation in South Africa.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026